Meta AnalysisID 7512
他汀类药物使用与性别特异性新发糖尿病风险：随机试验的Meta分析（伞状评价）
CRD42023465344
To determine the association of statin treatment with incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary and/or secondary prevention of cardiovascular disease. To est
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7512
- Evidence Id
- 16070
- Core Evidence Id
- 16070
- Source Meta Analysis Id
- 7750
- Herb2 Meta Analysis Id
- HBMA007750
- Crd Id
- CRD42023465344
- Title
- Statin use and sex-specific risk of new-onset diabetes: a meta-analysis of randomized trials (umbrella review)
- Review Question
- To determine the association of statin treatment with incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary and/or secondary prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary or second prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for secondary prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary prevention of cardiovascular disease stratified by high vs. moderate CVD risk.
- Study Type Included
- Systematic reviews, meta-analyses
- Condition Being Studied
- Statin-associated diabetes
- Participant
- Adults >=18 years enrolled in a randomized placebo-controlled trial or crossover trial of statin vs. placebo for primary or secondary prevention of cardiovascular disease
- Animal
- Human Disease Modelled
- Intervention
- (“statin” or “hydroxymethylglutarylcoenzyme A reductase inhibitors” or “anticholesteremic agents” or “simvastatin” or “rosuvastatin” or “pravastatin” or “atorvastatin” or “fluvastatin” or “cerivastatin” or “pitavastatin” or “lovastatin”)
- Comparator Control
- Placebo
- Main Outcome
- Incident diabetes Measures of effect Relative risks, hazard ratios
- Outcome Measure
- Additional Outcome
- Study Method
- Meta-analysis, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Pandora (Luke) Wander [email protected]
- Organisational Affiliation
- VA Puget Sound Health Care System/University of Washington
- Funding Source
- No funding
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- United States of America
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-09-19
- Registration Date
- 2023-09-30
- Anticipated Start Date
- 2023-09-20
- Anticipated Completion Date
- 2023-12-20
- Title Cn
- 他汀类药物使用与性别特异性新发糖尿病风险：随机试验的Meta分析（伞状评价）
- Title En
- Statin use and sex-specific risk of new-onset diabetes: a meta-analysis of randomized trials (umbrella review)
- Bilingual Status
- complete